76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended…
ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well…
December 01, 2025 12:10 ET | Source: Airway Management, Inc. DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Airway Management, the…
Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix…
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…
A premium toothpaste scientifically designed to strengthen enamel and protect against acid wearNEW DELHI, Nov. 21, 2025 /PRNewswire/ -- Sensodyne, the…
MUMBAI, India, Nov. 18, 2025 /PRNewswire/ -- Teeth may not always be the first thing that comes to mind in…
In a recent episode of Breakfast with Champions, legendary cricketer and Head Coach Rahul Dravid brought critical attention to an…
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic…
In a significant step towards integrating oral healthcare into the realm of sports science, Manav Rachna Dental College (MRDC) in…